Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CASP3 | P42574 | 19/20 | 0.84 |
| ▸ | CASP7 | P55210 | 14/20 | 0.84 |
| ▸ | CASP1 | P29466 | 7/20 | 0.84 |
| ▸ | CASP6 | P55212 | 4/20 | 0.84 |
| ▸ | CASP9 | P55211 | 3/20 | 0.84 |
| ▸ | CASP2 | P42575 | 3/20 | 0.84 |
| ▸ | CASP4 | P49662 | 2/20 | 0.84 |
| ▸ | CASP8 | Q14790 | 2/20 | 0.84 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6535139 | 1.00 | CASP3 (0.84) | CASP3CASP7CASP1CASP6CASP9 | |
| SCHEMBL6535497 | 0.93 | CASP3 (0.82) | CASP3CASP7CASP1CASP6CASP9 | |
| SCHEMBL6535499 | 0.93 | CASP3 (0.82) | CASP3CASP7CASP1CASP6CASP9 | |
| SCHEMBL2259065 | 0.91 | CASP3 (0.82) | CASP3CASP7CASP1CASP6CASP9 | |
| SCHEMBL2259069 | 0.91 | CASP3 (0.82) | CASP3CASP7CASP1CASP6CASP9 | |
| SCHEMBL6535718 | 0.91 | CASP3 (0.82) | CASP3CASP7CASP1CASP6CASP9 | |
| SCHEMBL6535719 | 0.91 | CASP3 (0.82) | CASP3CASP7CASP1CASP6CASP9 | |
| SCHEMBL2263591 | 0.91 | CASP3 (1.00) | CASP3CASP7CASP1CASP6CASP9 | |
| SCHEMBL4094113 | 0.91 | CASP3 (1.00) | CASP3CASP7CASP1CASP6CASP9 | |
| SCHEMBL4143447 | 0.89 | CASP3 (1.00) | CASP3CASP7CASP1CASP6CASP9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1242081-A4 | CASPASES AND APOPTOSIS | SMITHKLINE BEECHAM CORP (US) | 2004-07-21 | — | — | EP | claimed |
| EP-1001933-A4 | CASPASES AND APOPTOSIS | SMITHKLINE BEECHAM CORP (US) | 2002-11-06 | — | — | EP | claimed |
| EP-1242081-A1 | CASPASES AND APOPTOSIS | SmithKline Beecham Corporation (US) | 2002-09-25 | — | — | EP | claimed |
| US-6403792-B1 | INHIBIT PRODUCTION OF CASPASE 3 AND 7 IN MAMMALS | SMITHKLINE BEECHAM CORPORATION | 2002-06-11 | — | — | US | claimed |
| WO-2001022966-A1 | CASPASES AND APOPTOSIS | SMITHKLINE BEECHAM CORPORATION (US) | 2001-04-05 | — | — | WO | claimed |
| EP-1001933-A1 | CASPASES AND APOPTOSIS | SMITHKLINE BEECHAM CORPORATION (US) | 2000-05-24 | — | — | EP | claimed |
| WO-1999006367-A1 | CASPASES AND APOPTOSIS | SMITHKLINE BEECHAM CORPORATION (US) | 1999-02-11 | — | — | WO | claimed |
| EP-1242081-A4 | CASPASES AND APOPTOSIS | SMITHKLINE BEECHAM CORP (US) | 2004-07-21 | — | — | EP | disclosed |
| EP-1242081-A1 | CASPASES AND APOPTOSIS | SmithKline Beecham Corporation (US) | 2002-09-25 | — | — | EP | disclosed |
| US-6403792-B1 | INHIBIT PRODUCTION OF CASPASE 3 AND 7 IN MAMMALS | SMITHKLINE BEECHAM CORPORATION | 2002-06-11 | — | — | US | disclosed |
| WO-2001022966-A1 | CASPASES AND APOPTOSIS | SMITHKLINE BEECHAM CORPORATION (US) | 2001-04-05 | — | — | WO | disclosed |